van Hooft Jeanin E, Dijkgraaf Marcel G W, Timmer Robin, Siersema Peter D, Fockens Paul
Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
Scand J Gastroenterol. 2010 Oct;45(10):1217-22. doi: 10.3109/00365521.2010.487916.
Gastric outlet obstruction (GOO) is one of the late complications of a variety of malignancies. Palliation of symptoms of obstruction rather than cure is the primary aim of treatment in affected patients. Thus far prognostic information on life expectancy is lacking in these patients although it can be of importance when deciding upon their optimal treatment. The purpose of this study was to investigate whether baseline data in patients with incurable GOO can independently predict survival.
In total, 105 consecutive patients with symptomatic GOO treated with duodenal stent placement were enrolled in this multicenter prospective observational study. Patients were followed until death or till 1 November 2008. The Cox proportional hazard regression model was used for both univariate and multivariate analyses of survival.
Baseline data of 101 patients were completed. At the time of analysis, 95% of patients had died; median overall survival was 82 days (75% alive at 36 days, 25% alive at 156 days). The final prediction model revealed the dichotomized WHO performance status (HR: 2.63, 95% CI: 1.68-4.12, p < 0.001), prescription of morphines stronger than tramadol (HR: 2.42, 95% CI: 1.38-4.25, p = 0.002) and pain score of the EORTC QLQ-C30 (HR: 1.01, 95% CI: 1.00-1.01, p = 0.035) as independent significant prognostic factors for short survival.
This study demonstrates clear predictors of poor outcome for patients presenting with symptomatic malignant GOO. The model may enhance the selection of optimal treatment for individual patients.
胃出口梗阻(GOO)是多种恶性肿瘤的晚期并发症之一。缓解梗阻症状而非治愈是这类患者治疗的主要目标。尽管在决定最佳治疗方案时,患者的预期寿命预后信息可能很重要,但目前这类患者仍缺乏相关信息。本研究旨在探讨无法治愈的GOO患者的基线数据是否能独立预测生存情况。
本多中心前瞻性观察研究共纳入105例因十二指肠支架置入术治疗有症状GOO的连续患者。对患者进行随访直至死亡或至2008年11月1日。采用Cox比例风险回归模型对生存情况进行单因素和多因素分析。
101例患者的基线数据完整。在分析时,95%的患者已死亡;中位总生存期为82天(36天时75%存活,156天时25%存活)。最终预测模型显示,世界卫生组织(WHO)二分体能状态(风险比:2.63,95%置信区间:1.68 - 4.12,p < 0.001)、比曲马多更强效的吗啡处方(风险比:2.42,95%置信区间:1.38 - 4.25,p = 0.002)以及欧洲癌症研究与治疗组织(EORTC)QLQ - C30疼痛评分(风险比:1.01,95%置信区间:1.00 - 1.01,p = 0.035)是短期生存的独立显著预后因素。
本研究明确了有症状恶性GOO患者预后不良的预测因素。该模型可优化个体患者的最佳治疗选择。